Skip to main content
. 2020 Jun 9;12(6):1511. doi: 10.3390/cancers12061511

Figure 5.

Figure 5

An example of an HR+/HER2− breast cancer patient who had neoadjuvant chemotherapy being monitored by MRI. The serial apparent diffusion coefficient (ADC) maps, obtained from diffusion-weighted (DW) MRI (b = 800 mm2/s), show an increase in value with treatment. Compared to baseline, ∆ADC = +9.5% at early treatment; +14% at inter-regimen and +29% at pre-surgery.